Cholesterol efflux capacity (CEC), commonly measured as a useful risk marker of atherosclerotic cardiovascular disease, depends on high-density lipoprotein (HDL) functionality and its concentration. We defined the relative HDL functionality in cholesterol efflux, not influenced by HDL concentration, as th...
Atherosclerotic coronary artery disease:Over time, a sticky, fatty substance called plaque can build up in your arteries. That makes it harder for blood to get through and raises your risk for a heart attack or stroke. Atherosclerotic coronary artery disease is when plaque builds up along the w...
Atherosclerotic coronary artery disease:Over time, a sticky, fatty substance called plaque can build up in your arteries. That makes it harder for blood to get through and raises your risk for a heart attack or stroke. Atherosclerotic coronary artery disease is when plaque builds up along the w...
This is consistent with the established relationship between E-selectin gene polymorphism or serum soluble E-selectin level and atherosclerotic vascular disease, such as coronary heart disease, ischemic stroke and kidney injury.6,17,18 Therefore, E-selectin is intri- cately involved in the etiology...
It is widely acknowledged that in the intricate pathogenesis of coronary atherosclerotic disease (CAD), inflammation assumes a pivotal role [26]. The activation of inflammatory cells within atherosclerotic plaques renders them unstable, fostering thrombotic events. A heightened leukocyte count, as an ...
Effects of atorvastatin and ezetimibe on CD147, HIF-1, MMP-2 and VEGF in carotid atherosclerotic plaque under the guidance of IVUS Atherosclerosis (AS), as the main pathophysiological basis of coronary heart disease, can develop into carotid atherosclerotic plaque (CAP) through intimal... H Xie...
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of premature death worldwide [1]. The increase in early-onset coronary artery disease (EOCAD) has become an emerging public health concern [2,3,4]. Patients with EOCAD were more likely than their older counterparts to be treated...
Considering the inclusion of patients with manifest atherosclerotic cardiovascular disease, we observed a rather low rate of atherothrombotic events during follow-up. This may be due to 1. the inclusion of stable PAD patients undergoing elective infrainguinal angioplasty and stenting because of intermitte...
Antiplatelet agents are protective in a variety of atherosclerotic cardiac and vascular diseases, including acute myocardial infarction (MI), ischemic stroke, non-ST elevation acute coronary syndrome (NSTE-ACS), stable angina, and peripheral artery disease (PAD). Although aspirin is the mainstay of ...
"That's why it's not mentioned" to patients, he said. "What is really needed is to inform physician colleagues that Lp(a) is not only a risk factor but is the cause" of atherosclerotic cardiovascular disease (ASCVD). Kronenberg said that the pressure for testing can often come from the...